Global Metabolic Testing Market Size (2024 - 2029)

The metabolic testing market is projected to experience significant growth, driven by the rising prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular conditions. The market's expansion is further supported by technological advancements and increased health consciousness among the population. The COVID-19 pandemic has also contributed to a heightened demand for metabolic testing due to the surge in sedentary lifestyles and unhealthy dietary habits. Despite these growth drivers, the high cost of equipment and software poses a challenge to market expansion.

Market Size of Global Metabolic Testing Industry

Metabolic Testing Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 558.74 Million
Market Size (2029) USD 796.93 Million
CAGR (2024 - 2029) 7.36 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Metabolic Testing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Metabolic Testing Market Analysis

The Global Metabolic Testing Market size is estimated at USD 558.74 million in 2024, and is expected to reach USD 796.93 million by 2029, growing at a CAGR of 7.36% during the forecast period (2024-2029).

The COVID-19 pandemic significantly impacted the metabolic testing market due to increased sedentary lifestyles and reduced physical activities due to the lockdown. For instance, as per the article published in March 2021 in MedRxiv journal, the COVID-19 epidemic increased sedentary lifestyles and unhealthy dietary habits. As a result of the increase in metabolic diseases caused by unhealthy dietary habits, the demand for metabolic testing soared during the pandemic. In the post-pandemic situation, as the restrictions were lifted, the market is likely to witness growth due to the rise in obesity and other metabolic disorders coupled with the advancements in metabolic testing.

The market is primarily driven by the growing incidence and prevalence rate of various lifestyle-related diseases such as heart diseases, hypertension, high cholesterol, diabetes, and obesity worldwide and technological advances in metabolic testing. For instance, as per the World Obesity Atlas 2022, by 2030, it is predicted that 1 in 5 women and 1 in 7 men are likely to be living with obesity, equating to over 1 billion people globally.

Similarly, as per America's Health Rankings, 35.7% of adults reported having their cholesterol checked and considered high in 2021 in the United States. As per the same source, 14.2% of adults reported by a health professional that they had angina or coronary heart disease, a heart attack or myocardial infarction, or a stroke in West Virginia in 2021. Thus, the high burden of diseases is expected to increase the demand for metabolic testing. Additionally, as per the May 2021 data from the WHO, about 1.13 billion people worldwide have hypertension, of which two-thirds live in low- and middle-income countries. Thus, with the growing prevalence of such lifestyle diseases, the demand for metabolic testing is expected to increase as a growing trend toward monitoring health parameters.

Factors such as a huge pool of obese patients, an increase in the prevalence of metabolic disorders, technological advancements, and rising health and fitness consciousness are expected further to augment the market's growth over the forecast period. For instance, in February 2022, AliveCor launched KardiaMobile Card, the slimmest, most convenient personal ECG device which fits easily into any wallet and delivers a medical-grade, single-lead ECG in 30 seconds. Additionally, numerous awareness programs run globally to emphasize the significance of testing and treatment options for metabolic diseases. For instance, in May 2022, the American Liver Foundation conducted a countrywide screening and public awareness program, 'Think Liver Think Life,' to test at-risk children and adults in all 50 states over the next five years to address the increase in fatty liver disease.

Therefore, the increasing prevalence of lifestyle diseases such as cardiovascular disease, obesity, and diabetes, technological advancements, and healthcare expenditure are the key driving factors in the metabolic testing market. However, the high cost of Equipment and Software restrains the market growth over the forecast period.

Metabolic Testing Industry Segmentation

As per the scope of the report, metabolic testing provides information about how effectively a person's body burns calories and uses oxygen during workouts. The tests assess hormones, chemical byproducts, and other metabolic markers in a person's breath, blood, or saliva. The Metabolic Testing Market is Segmented by Product Type (Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, ECG Systems, Metabolic Carts, Others), Application (Critical Care, Lifestyle Diseases), End User (Hospitals and, Clinics, Sports Training Centers, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.

By Equipment Type
Body Composition Analyzers
Cardiopulmonary Exercise Testing (CPET) Systems
ECG Systems
Metabolic Carts
Others
By Application
Critical Care
Lifestyle Diseases
By End User
Hospitals and Clinics
Sports Training Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Metabolic Testing Market Size Summary

The metabolic testing market is poised for significant growth, driven by the increasing prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular conditions. The market's expansion is further supported by technological advancements in testing methods and a growing awareness of health monitoring. The COVID-19 pandemic has accelerated the demand for metabolic testing due to the rise in sedentary lifestyles and associated metabolic disorders. As restrictions have eased, the market is expected to benefit from the ongoing trend of health consciousness and the need for regular monitoring of metabolic health parameters. The introduction of innovative devices and strategic initiatives by key players are also contributing to the market's dynamic growth trajectory.

North America is anticipated to maintain a substantial share of the metabolic testing market, bolstered by its advanced healthcare infrastructure and increasing incidence of metabolic diseases. The region's market growth is further enhanced by investments in developing cutting-edge metabolic devices and a strong focus on health awareness. The fragmented nature of the market, with several key players like MGC Diagnostics Corporation and COSMED Srl, indicates a competitive landscape where innovation and strategic collaborations are crucial. The demand for body composition analyzers and other testing equipment is expected to rise, driven by the need for effective monitoring and management of metabolic health, particularly in emerging markets with a high burden of obesity and related disorders.

Explore More

Global Metabolic Testing Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Incidence of Lifestyle Diseases

      2. 1.2.2 Technological Advancements in Metabolic Testing

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Equipment and Software

      2. 1.3.2 Poor Reimbursement Policies

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Equipment Type

      1. 2.1.1 Body Composition Analyzers

      2. 2.1.2 Cardiopulmonary Exercise Testing (CPET) Systems

      3. 2.1.3 ECG Systems

      4. 2.1.4 Metabolic Carts

      5. 2.1.5 Others

    2. 2.2 By Application

      1. 2.2.1 Critical Care

      2. 2.2.2 Lifestyle Diseases

    3. 2.3 By End User

      1. 2.3.1 Hospitals and Clinics

      2. 2.3.2 Sports Training Centers

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Metabolic Testing Market Size FAQs

The Global Metabolic Testing Market size is expected to reach USD 558.74 million in 2024 and grow at a CAGR of 7.36% to reach USD 796.93 million by 2029.

In 2024, the Global Metabolic Testing Market size is expected to reach USD 558.74 million.

Metabolic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)